|
 The outbreak was contained using Merck's Ebola vaccine, which was
given to more than 1,600 of the patients' contacts and contacts of
contacts, according to the aid group Medecins Sans Frontieres (MSF).
The cases were genetically linked to the 2018-20 Ebola epidemic that
killed more than 2,200 people, the second-highest toll recorded in
the disease's history.
The flare-up emerged on Feb. 3. In the city of Butembo with the
death of a woman whose husband had contracted the virus in the
previous outbreak.
Ebola causes fever, bleeding, vomiting and diarrhoea and spreads
among humans through bodily fluids.
[to top of second column] |
 "I am pleased to solemnly
declare the end of the 12th epidemic of Ebola
virus disease in North Kivu Province," health
minister Jean-Jacques Mbungani said in a
statement.
"Despite the security context and the COVID-19
pandemic, the rapidity and efficiency of the
response put in place by the government and its
partners made it possible to defeat this
pandemic in less than 3 months," he said.
(Reporting by Jessica Agasaro; Writing by
Hereward Holland; Editing by Bate Felix and
Andrew Heavens)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |
